Leading Biosciences, Inc.
Records under this name other than the patents Leading Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 4 of 4 · Back to Leading Biosciences, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,439,611 | Administration of Serine Protease Inhibitors to the Stomach Lapsed on the fee record Ended Sep 13, 2026 · High confidence | Lapsed on the fee record | Ended Sep 13, 2026 | High confidence |
| US 11,202,768 | Compositions and methods for treating and preventing adhesions and ileus Lapsed on the fee record Ended Dec 21, 2025 · USPTO record | Lapsed on the fee record | Ended Dec 21, 2025 | USPTO record |
| US 9,775,821 | Compositions for the treatment of autodigestion Lapsed on the fee record Ended Oct 3, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 3, 2025 | USPTO record |
| US 11,123,317 | Compositions for the treatment of autodigestion Lapsed on the fee record Ended Sep 21, 2025 · USPTO record | Lapsed on the fee record | Ended Sep 21, 2025 | USPTO record |